当前位置:首页 - 行情中心 - 九洲药业(603456) - 财务分析 - 资产负债表

九洲药业

(603456)

  

流通市值:132.85亿  总市值:132.85亿
流通股本:8.95亿   总股本:8.95亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金2,666,564,321.442,959,285,845.144,059,468,406.23,206,427,316.5
应收票据及应收账款1,239,658,388.111,347,373,968.261,584,336,245.94962,281,411.93
应收账款1,239,658,388.111,347,373,968.261,584,336,245.94962,281,411.93
应收款项融资70,147,085.1360,394,430.449,898,118.0935,403,591.21
预付款项36,544,032.0843,744,909.535,554,637.7631,040,327.04
其他应收款合计19,910,747.29,227,275.5111,032,790.038,316,389.94
存货1,964,842,138.191,836,343,082.461,803,821,044.741,959,410,718.77
其他流动资产148,349,650.66120,575,036.292,445,669.37111,508,423.33
流动资产平衡项目0000
流动资产合计6,146,016,362.816,376,944,547.477,636,556,912.136,314,388,178.72
非流动资产:
长期股权投资31,475,203.1750,376,596.253,362,867.5855,704,833.79
其他非流动金融资产80,640,843.6381,172,203.9766,172,203.9766,172,203.97
固定资产2,686,339,404.552,565,663,261.82,461,233,284.912,505,616,965.14
在建工程1,366,484,672.011,347,391,532.941,324,546,425.391,198,288,365.96
使用权资产16,638,811.5815,593,986.8416,836,220.4318,402,864.38
无形资产507,165,809.31506,797,141.24496,608,095.98504,743,873.66
开发支出56,356,159.7658,946,675.7772,118,718.4467,193,760.23
商誉109,392,021.21109,630,895.38109,869,769.55110,108,643.72
长期待摊费用4,914,069.215,298,212.737,457,937.846,011,124.16
递延所得税资产165,202.77256,876.331,379,754.96749,179.12
其他非流动资产2,992,518.453,173,727.573,664,226.474,607,363.84
非流动资产平衡项目0000
非流动资产合计4,862,564,715.654,744,301,110.774,613,249,505.524,537,599,177.97
资产平衡项目0000
资产总计11,008,581,078.4611,121,245,658.2412,249,806,417.6510,851,987,356.69
流动负债:
短期借款--1,291,179,805.55-
应付票据及应付账款1,222,093,347.651,120,754,978.131,189,529,738.961,197,601,168.76
其中:应付票据361,255,055.51253,552,638.85223,434,234.84280,413,441
应付账款860,838,292.14867,202,339.28966,095,504.12917,187,727.76
合同负债91,859,520.0266,801,900.8749,497,342.7975,413,836.94
应付职工薪酬141,454,957.05127,819,410.6110,250,096.34184,068,387.45
应交税费54,698,292.5767,802,904.5179,603,318.7101,141,526.8
其他应付款合计48,618,729.08521,746,622.9177,876,437.7976,832,871.25
应付股利-445,387,214--
一年内到期的非流动负债116,327,025.5516,476,96914,304,590.3314,542,527.76
其他流动负债10,286,555.356,149,883.064,454,883.077,019,689.1
流动负债平衡项目0000
流动负债合计1,685,338,427.271,927,552,669.082,816,696,213.531,656,620,008.06
非流动负债:
长期借款375,953,837.8420,207,063.23398,394,412.82389,050,000
租赁负债8,737,808.9711,414,007.1211,399,007.8411,894,656.08
长期应付职工薪酬75,132,602.8267,022,216.7857,155,945.5150,766,508.08
递延收益121,708,102.79110,176,212.79113,698,837.06109,115,829.06
递延所得税负债118,633,787.2116,604,722.51116,659,775.61101,469,462.2
非流动负债平衡项目0000
非流动负债合计700,166,139.58725,424,222.43697,307,978.84662,296,455.42
负债平衡项目0000
负债合计2,385,504,566.852,652,976,891.513,514,004,192.372,318,916,463.48
所有者权益(或股东权益):
实收资本(或股本)899,435,228899,435,228899,485,928899,485,928
资本公积4,504,607,538.424,500,553,114.364,501,034,564.254,499,415,450.66
减:库存股230,709,725.51230,709,725.51172,006,726.56132,005,605.36
其他综合收益-4,515,258.441,066,574.91,718,713.93-644,207.66
专项储备5,271,495.996,175,276.397,874,902.785,297,372.23
盈余公积296,386,518.34296,386,518.34296,386,518.34296,386,518.34
未分配利润3,078,687,091.832,922,799,026.443,129,956,475.42,893,197,600.01
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计8,549,162,888.638,395,706,012.928,664,450,376.148,461,133,056.22
少数股东权益73,913,622.9872,562,753.8171,351,849.1471,937,836.99
股东权益平衡项目0000
股东权益合计8,623,076,511.618,468,268,766.738,735,802,225.288,533,070,893.21
负债和股东权益合计11,008,581,078.4611,121,245,658.2412,249,806,417.6510,851,987,356.69
公告日期2024-10-252024-08-272024-04-252024-04-09
审计意见(境内)标准无保留意见
TOP↑